Dr James Marangou

Honorary Research Fellow

Qualifications:

FRACP, Royal Australasian College of Physicians, 2017; MBBS (hons), University of Western Australia, 2009;

Location:

Darwin – Royal Darwin Hospital

Biography:

Dr James Marangou is a consultant cardiologist at Royal Darwin Hospital and a PhD candidate with Menzies School of Health Research and Charles Darwin University. His PhD is supported by an National Health and Medical Research Council post-graduate scholarship. His broad research interests are cardiovascular health in Australian Indigenous populations and rural and remote cardiology service provision. His PhD focuses on the implementation and impact of echocardiography screening for rheumatic heart disease during pregnancy in high risk populations.

  1. Marangou, J., Beaton, A., Aliku, T. O., Nunes, M., Kangaharan, N., & Reményi, B. (2019). Echocardiography in Indigenous Populations and Resource Poor Settings. Heart, lung & circulation, 28(9), 1427–1435. https://doi.org/10.1016/j.hlc.2019.05.176
  2. Bradshaw, P. J., Tohira, H., Marangou, J., Newman, M., Reményi, B., Wade, V., Reid, C., & Katzenellenbogen, J. M. (2020). The use of cardiac valve procedures for rheumatic heart disease in Australia; a cross-sectional study 2002-2017. Annals of medicine and surgery (2012), 60, 557–565. https://doi.org/10.1016/j.amsu.2020.11.055
  3. Francis, J. R., Fairhurst, H., Hardefeldt, H., Brown, S., Ryan, C., Brown, K., Smith, G., Baartz, R., Horton, A., Whalley, G., Marangou, J., Kaethner, A., Draper, A. D., James, C. L., Mitchell, A. G., Yan, J., Ralph, A., & Remenyi, B. (2020). Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening. The Medical journal of Australia, 213(3), 118–123. https://doi.org/10.5694/mja2.50682
  4. Giudicatti, L., Marangou, J., Nolan, D., Dembo, L., Baumwol, J., & Dwivedi, G. (2020). The Utility of Whole Body 18F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study. Heart, lung & circulation, 29(1), e1–e6. https://doi.org/10.1016/j.hlc.2019.07.007
  5. Ng, J., Downton, T., Davidson, N., & Marangou, J. (2019). Corynebacterium diphtheriae-infective endocarditis in a patient with an atrial septal defect closure device. BMJ case reports, 12(5), e229478. https://doi.org/10.1136/bcr-2019-229478
  6. Marangou, J., Redfern, A., Haddad, T., Rankin, J. M., & Dwivedi, G. (2018). Heart failure following oncological treatment. Current opinion in cardiology, 33(2), 237–244. https://doi.org/10.1097/HCO.0000000000000488
  7. Marangou, J., & Paul, V. (2015). Current attitudes on cardiac devices in heart failure: a review. Clinical therapeutics, 37(10), 2206–2214. https://doi.org/10.1016/j.clinthera.2015.08.012